Synacthen ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
78Hypopituitarism3

78. Hypopituitarism


Clinical trials : 494 Drugs : 385 - (DrugBank : 49) / Drug target genes : 44 - Drug target pathways : 100
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00851942
(ClinicalTrials.gov)
September 200825/2/2009Determination of Method-specific Normal Cortisol and Adrenal Hormone Responses to the Short Synacthen TestDetermination of Method-specific Normal Cortisol and Adrenal Hormone Responses to the Short Synacthen TestHealthy;Adrenal Insufficiency;HypopituitarismDrug: Synacthen (Tetracosactrin)Cardiff UniversityNULLCompleted18 Years80 YearsAll165Phase 4United Kingdom
2EUCTR2007-000056-14-GB
(EUCTR)
03/03/200804/01/2008Determination of method-specific normal cortisol and adrenal hormone responses to the short Synacthen test - Short Synacthen test StudyDetermination of method-specific normal cortisol and adrenal hormone responses to the short Synacthen test - Short Synacthen test Study Normal, healthy volunteers to establish a reference range for the synacthen test, plus patients with hypoadrenalism/hypopituitarism
MedDRA version: 9.1;Level: LLT;Classification code 10020936;Term: Hypoadrenalism
MedDRA version: 9.1;Classification code 10021067;Term: Hypopituitarism
Trade Name: SynacthenCardiff UniversityNULLNot Recruiting Female: yes
Male: yes
240 Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): yesUnited Kingdom
3NCT00552487
(ClinicalTrials.gov)
October 200531/10/2007Isolated ACTH Deficiency in Patients With Hashimoto ThyroiditisIsolated ACTH Deficiency in Patients With Hashimoto ThyroiditisHashimoto Disease;Adrenal InsufficiencyDrug: synacthenUniversity of WuerzburgNULLCompleted18 YearsN/ABoth62N/AGermany